NCT03652324

What Should be the Anesthesia Method in Endobronchial Coil Treatment

Completed NA Last updated 31 August 2018

What this trial tests

NA trial testing method in Coil Treatment in 32 participants. Completed in 28 August 2018.

Timeline

28 March 2018

Primary endpoint
28 August 2018

28 August 2018

Quick facts

Lead sponsor	TC Erciyes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	32
Start date	28 March 2018
Primary completion	28 August 2018
Estimated completion	28 August 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• method

Conditions studied

• Coil Treatment — all drugs for Coil Treatment →
• Deep Sedation — all drugs for Deep Sedation →

Sponsor

TC Erciyes University

Who can join

Eligibility, any sex, with Coil Treatment or Deep Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, randomize study was conducted in a university hospital. Bronchoscopic lung volume reduction (BLVR) coil treatment has recently been introduced into clinical practice as an alternative for patients chronic obstructive pulmonary disease (COPD) with severe refractory heterorogenous emphysema to conventional medical treatment. Thirty two patients diagnosed with (COPD) with severe refractory heterorogenous emphysema undergoing BLVR coil treatment were included in the study. Seventeen procedure were performed under general anesthesia and fifteen procedure were performed under deep sedation-analgesia. in the general anesthesia group peak pressure, air leakage and end-tidal carbon dioxide were recorded. In the both groups pulse oximeter, transcutaneous carbondioxide, recovery time, bronchospasm, laryngospasm, pneumothorax, massive bleeding were recorded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.